Company News, Financial News, People News

Sales Jump 8.7% at Lonza

For the year, specialty ingredients were big business.

Throughout 2016, Lonza continued to deliver record financial results with outstanding improvements across all key performance indicators, leading to the best-ever full-year results in the company’s history, it said. It recorded strong sales growth of 8.7% to $4.1 billion. The outstanding improvements were particularly driven by commercial excellence and strong operational execution in the Pharma&Biotech segment, said the company.   The Specialty Ingredients segment posted sustained str...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters